LGT Fund Management »

Immix Biopharma shares owned by LGT Fund Management

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by LGT Fund Management from 13F filings

Historical chart of LGT Fund Management investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by LGT Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by LGT Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $660k 125k 5.28

More positions owned by LGT Fund Management

Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Coca-Cola Company (KO)
Broadcom (AVGO)
S&p Global (SPGI)
Blackrock (BLK)
Palo Alto Networks (PANW)

View all positions for LGT Fund Management

Top funds holding Immix Biopharma

Saturn V Capital Management
Eventide Asset Management
Marshall Wace
Vanguard Group
Logos Global Management
Bleichroeder
Blue Owl Capital Holdings
Franklin Resources
Susquehanna International
Renaissance Technologies
Geode Capital Management
KVP Capital Advisors
Goldman Sachs Group
Jane Street
LGT Fund Management

View all funds holding Immix Biopharma